MedTrace Logo

A Clinical Trial Investigating the Effect of Salmon Bone Meal on Osteoarthritis Among Men and Women

NCT05070871 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 98

Last updated 2024-02-13

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy of hydrolyzed collagen in osteoarthritis.

Conditions

Interventions

DIETARY_SUPPLEMENT

Hydrolyzed Collagen

Hydrolyzed collagen type II derived from the bone powder of Norwegian Atlantic salmon.

OTHER

Placebo

Pure maltodextrin.

DIETARY_SUPPLEMENT

CalGo

CalGo is a natural marine collagenic bone powder from salmon. The bone powder is a 100 % microcrystalline hydroxyapatite form of calcium and collagen type 2.

Sponsors & Collaborators

  • Møre og Romsdal Hospital Trust

    collaborator OTHER

  • Hofseth Biocare ASA

    lead INDUSTRY

Principal Investigators

  • Øystein Bjerkestrand Lian, MD, PhD · Møre og Romsdal Hospital Trust (Helse Møre og Romsdal), Kristiansund Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-22
Primary Completion
2023-12-27
Completion
2024-01-15

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05070871 on ClinicalTrials.gov